Cianopramine
![]()  | |
| Clinical data | |
|---|---|
| ATC code | 
  | 
| Identifiers | |
IUPAC name 
  | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C20H23N3 | 
| Molar mass | 305.425 g·mol−1 | 
| 3D model (JSmol) | |
SMILES 
  | |
Cianopramine (INN) (developmental code name Ro 11-2465), also known as 3-cyanoimipramine, is a tricyclic antidepressant related to imipramine that acts as a serotonin reuptake inhibitor[1] and weak serotonin receptor antagonist.[2][3] It was investigated for the treatment of depression but was never marketed.[3]
See also
References
- ↑ Kenny M, Lenehan TJ, Lambe R, Darragh A, Brick I, Omer LM (1983). "Effects of a single oral dose of 3-cyano-imipramine on serotonin uptake and content of platelets in healthy volunteers". Psychopharmacology. 79 (4): 304–7. doi:10.1007/bf00433406. PMID 6407042. S2CID 3112636.
 - ↑ Pawłowski L, Kwiatek H, Górka Z (1981). "Is Ro 11-2465 (cyan-imipramine) an antagonist of postsynaptic serotonin receptors?". Journal of Neural Transmission. 52 (1–2): 61–72. doi:10.1007/BF01253098. PMID 7288439. S2CID 41042435.
 - 1 2 Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 270–. ISBN 978-1-4757-2085-3.
 
| 5-HT1ARTooltip 5-HT1A receptor agonists | |
|---|---|
| GABAARTooltip GABAA receptor PAMsTooltip positive allosteric modulators | 
  | 
| Hypnotics | |
| Gabapentinoids (α2δ VDCC blockers)  | |
| Antidepressants | 
  | 
| Antipsychotics | |
| Sympatholytics (Antiadrenergics)  | 
  | 
| Others | |
  | |
Acetylcholine receptor modulators  | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 
  | |||||||||||||||||||||||||
Adrenergic receptor modulators  | |||||
|---|---|---|---|---|---|
| α1 | 
  | ||||
| α2 | 
  | ||||
| β | 
  | ||||
  | |||||
Histamine receptor modulators  | |||||
|---|---|---|---|---|---|
| H1 | 
  | ||||
| H2 | 
  | ||||
| H3 | 
  | ||||
| H4 | 
  | ||||
  | |||||
| DATTooltip Dopamine transporter (DRIsTooltip Dopamine reuptake inhibitors)  | 
  | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NETTooltip Norepinephrine transporter (NRIsTooltip Norepinephrine reuptake inhibitors)  | 
  | ||||||||||||||
| SERTTooltip Serotonin transporter (SRIsTooltip Serotonin reuptake inhibitors)  | 
  | ||||||||||||||
| VMATsTooltip Vesicular monoamine transporters | 
  | ||||||||||||||
| Others | 
 
  | ||||||||||||||
See also: Receptor/signaling modulators • Monoamine releasing agents • Adrenergics • Dopaminergics • Serotonergics • Monoamine metabolism modulators • Monoamine neurotoxins  | |||||||||||||||
Serotonin receptor modulators  | |||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5-HT1 | 
  | ||||||||||||||||||||||||||||||||||||||
| 5-HT2 | 
  | ||||||||||||||||||||||||||||||||||||||
| 5-HT3–7 | 
  | ||||||||||||||||||||||||||||||||||||||
  | |||||||||||||||||||||||||||||||||||||||
| Classes | 
  | 
|---|---|
| Antidepressants (Tricyclic antidepressants (TCAs))  | 
  | 
| Antihistamines | 
  | 
| Antipsychotics | 
  | 
| Anticonvulsants | |
| Anticholinergics | |
| Others | 
  | 
    This article is issued from Wmcloud. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
